Skip to main content
Equibles

MetLife Investment Management, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1529735 Whippany, NJ
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$959,161
+$422,243 QoQ
Shares Held
140,846
+17.3% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 208 holders
Holding Since
Jun 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. TSHA ranks #87 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in TSHA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $959,161 140,846
2026-03-31 $536,918 120,116
2025-12-31 $622,963 113,266
2025-09-30 $415,433 127,044
2025-06-30 $249,660 108,078
2025-03-31 $149,718 107,711
2024-12-31 $108,972 62,990
2024-09-30 $152,834 76,037
2024-06-30 $93,618 41,794
2021-12-31 $110,779 9,509
2021-09-30 $177,057 9,509
2021-06-30 $201,590 9,509